يحاول ذهب - حر
Apple Got the Jump on Tariffs, Deciding Years Ago to Make iPhones in India
August 09, 2025
|Mint Ahmedabad
India's iPhone production capacity is expected to more than double when two new production centers gear up in the next two years
Dozens of women wearing ID badges streamed from their rooms in a year-old dormitory for Foxconn workers and headed to a company cafeteria on a recent day for a menu of lentil-and-vegetable stew, beetroot and rice. White buses waited outside to ferry them to a factory where the Apple contractor builds iPhones.
Women working on assembly lines in India form the backbone of a strategy Apple Chief Executive Tim Cook set in motion years ago. He first looked to boost Apple's position in India's growing smartphone market after sales in China slowed. Those early steps now leave Apple well-positioned for the intensifying trade rivalry between the U.S. and China.
A year after a 2016 meeting between Indian Prime Minister Narendra Modi and Cook, the company began assembling iPhones in India on a relatively small scale. Apple next pushed suppliers to develop India as an alternative manufacturing hub when President Trump in his first term threatened tariffs on Chinese-made iPhones and, later, when the pandemic slowed iPhone production in China.
The company saw India as the only country outside of China that could assemble iPhones at adequate scale and competitive cost. India's iPhone production capacity is expected to more than double when two new production centers gear up in the next two years. That will allow Apple to increasingly rely on India, instead of China, to supply iPhones to the U.S.
Cook said last week that most iPhones sold in the U.S. came from India during the April-to-June quarter. He didn't elaborate on Apple's long-term plans for supplying the U.S. The company, which declined to comment, reported iPhone revenue in the last fiscal year at $201 billion.
هذه القصة من طبعة August 09, 2025 من Mint Ahmedabad.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Ahmedabad
Mint Ahmedabad
'If you're on trend, you are in trouble'
Patou creative head Guillaume Henry discusses the essence of couture and why simple is best
4 mins
December 13, 2025
Mint Ahmedabad
GST cuts, easing inflation drive rural demand revival
India’s rural economy expanded and recovered strongly in late 2025, with consumption, incomes and investment improving after a key tax reform and as inflation eased, a survey showed.
2 mins
December 13, 2025
Mint Ahmedabad
Chair man, of the bored
STREAM OF STORIES
3 mins
December 13, 2025
Mint Ahmedabad
Anju Dodiya creates disquieting worlds
Artist Anju Dodiya discusses the ideas, influences and inspiration behind her new solo show, 'The Geometry of Ash'
5 mins
December 13, 2025
Mint Ahmedabad
Bar hopping with Lounge
\"The things that make a cocktail really great are often very simple details—the frozen glass, the lemon twist—that transform two fingers of alcohol into an ice-glazed elixir,\" writes Alice Lascelles in her excellent guide to making cocktails at home, The Cocktail Edit.
1 mins
December 13, 2025
Mint Ahmedabad
New Delhi and France revise 1992 tax treaty
India and France have struck a deal to revise their 1992 treaty which will halve the tax on dividends paid by Indian units to French parents, potentially saving millions for companies with major operations in the South Asian nation, documents show.
1 min
December 13, 2025
Mint Ahmedabad
Ozempic debuts with a ₹2,200-a-week price tag
for chronic weight management, Novo Nordisk is positioning Ozempic as a treatment of type 2 diabetes with weight loss benefits, competing with Eli Lily’s Mounjaro that was launched in India in March.
1 mins
December 13, 2025
Mint Ahmedabad
How 'puri-aloo' and 'chaat' unite Lucknow
Whenever my friends want to eat puri-aloo, they invite themselves over to my home.
5 mins
December 13, 2025
Mint Ahmedabad
Novo Nordisk debuts Ozempic at ₹2,200 a week
Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of ₹2,200 per week.
1 mins
December 13, 2025
Mint Ahmedabad
Govt’s insurance reform allows 100% FDI, composite licences
The government has paved the way for 100% foreign direct investment in the insurance sector, composite licences and easier capital requirements, among others sweeping reforms, as the Union cabinet cleared the enabling legislation, said two officials aware of the matter.
1 mins
December 13, 2025
Listen
Translate
Change font size
